Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-23T08:36:01.404Z Has data issue: false hasContentIssue false
  • English
  • Français

Intracardiac thrombus associated with resistance to activated protein C

Published online by Cambridge University Press:  19 August 2008

Bernd Kohlhase ,
Deniz Kececioglu  and
Ulrike Nowak-Göttl
Bernd Kohlhase
Affiliation:
Department of Pediatric Cardiology, University Children's Hospital, Münster, Germany
Deniz Kececioglu*
Affiliation:
Department of Pediatric Cardiology, University Children's Hospital, Münster, Germany
Ulrike Nowak-Göttl
Affiliation:
Department of Pediatric Haematology/Oncology, University Children's Hospital, Münster, Germany
*
Deniz Kececioglu, MD. Westfälische Wilhelms-Universität Klinik und Poliklinik für Kinderheilkunde/Kinderkardiologie, Albert-Schweitzer-Str33, D-48 129 Münster, Germany. Tel: 0049-251/837705 Fax: 0049-251/837765
Get access Rights & Permissions [Opens in a new window]

Summary

Formation of thrombus in the heart is a rare event in children. Genetic risk factors determined for thrombophilia with additional exogenous risk factors may, none the less, promote cardiac thrombosis. We report on a boy without predisposing cardiac disease, heterozygous for resistance to activated protein C, who developed multiple thrombuses attached to the mitral valve which led to recurrent arterial throm boembolism. In addition this patient showed enhanced levels of lipoprotein (a).

Keywords

Intracadiac thrombosisactivated Protein C
Type
Brief Reports
Information
Cardiology in the Young , Volume 8 , Issue 1 , January 1998 , pp. 116 - 118
Copyright
Copyright © Cambridge University Press 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Özkutlu, S, Özbarlas, N, Ozme, S, SaraVlar, M, Gögus, S, Demircin, M. Intracardiac thrombosis diagnosed by echo cardioraphy in childhood: predisposing and etiological factors. Int J Cardiol 1993;40:251–256.CrossRefGoogle Scholar
2. Dahlbäck, B, Carlsson, M, Svensson, PJ. Familial throm bophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90: 1004–1008.CrossRefGoogle Scholar
3. Bertina, RM, Koeleman, BPC, Koster, T, Rosendaal, FR, Dirven, RJ, de Ronde, H, van der Velden, PA, Reitsma, PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369: 64–67.CrossRefGoogle ScholarPubMed
4. Dahlbäck, B. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg 506 to GIn mutation in factor V as a pathogenetic risk factor. Thromb Haemost 1995; 74: 139–148.Google Scholar
5. Mannucci, PM, Tripodi, A. Laboratory screening of inheritated thrombotic syndromes. Thromb Haemost 1987;57: 247–251.Google Scholar
6. Andrew, M. Developmental Hemostasis: Relevance of throm boembolic complications in pediatric patients. Thromb Haemost 1995,74:415–425.Google Scholar